Log in to save to my catalogue

Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitoc...

Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitoc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2342202207

Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability

About this item

Full title

Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability

Publisher

Greece: Spandidos Publications

Journal title

Oncology reports, 2020-02, Vol.43 (2), p.711-717

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications

More information

Scope and Contents

Contents

The aim of the present study was to investigate the metabolic and anticancer effects of troglitazone (TGZ) with a focus on the potential role of mitochondrial pyruvate utilization. 2‑Deoxyglucose (2‑DG) was more cytotoxic in CT26 cancer cells compared with T47D cells, despite a smaller suppression of glucose uptake. On the other hand, TGZ caused a...

Alternative Titles

Full title

Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2342202207

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2342202207

Other Identifiers

ISSN

1021-335X

E-ISSN

1791-2431

DOI

10.3892/or.2019.7436

How to access this item